Financial Ratios Advanced Micro-Fabrication Equipment Inc. China
Equities
688012
CNE100003MM9
Semiconductor Equipment & Testing
|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 344.50 CNY | -0.14% |
|
-1.35% | +26.32% |
| 02-11 | Advanced Micro-Fabrication Equipment China's Chairman Trims Stake | MT |
| 01-23 | Advanced Micro-Fabrication Equipment sees 2025 net profit up about 28.7-34.9% | RE |
| Fiscal Period: December | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|
Profitability | |||||||||
Return on Assets | 1.52 | 2.4 | 2.99 | 3.65 | 3.49 | ||||
Return on Total Capital | 1.98 | 2.95 | 3.66 | 4.49 | 4.28 | ||||
Return On Equity % | 12.12 | 11.05 | 7.94 | 10.71 | 8.6 | ||||
Return on Common Equity | 12.12 | 11.05 | 7.95 | 10.72 | 8.6 | ||||
Margin Analysis | |||||||||
Gross Profit Margin % | 37.4 | 43.27 | 44.92 | 44.99 | 39.06 | ||||
SG&A Margin | 17.14 | 16.04 | 13.6 | 13.34 | 10.6 | ||||
EBITDA Margin % | 6.97 | 15.1 | 19.25 | 20.33 | 15.94 | ||||
EBITA Margin % | 5.67 | 14.04 | 18.47 | 19.34 | 14.71 | ||||
EBIT Margin % | 5.66 | 13.91 | 18.53 | 19.4 | 14.69 | ||||
Income From Continuing Operations Margin % | 21.66 | 32.54 | 24.64 | 28.48 | 17.81 | ||||
Net Income Margin % | 21.65 | 32.54 | 24.68 | 28.51 | 17.82 | ||||
Net Avail. For Common Margin % | 21.65 | 32.54 | 24.68 | 28.51 | 17.82 | ||||
Normalized Net Income Margin | 4.48 | 13.01 | 14.58 | 20.87 | 10.39 | ||||
Levered Free Cash Flow Margin | 15.19 | 9.8 | -26.05 | -32.59 | -9.81 | ||||
Unlevered Free Cash Flow Margin | 15.2 | 9.81 | -25.99 | -32.44 | -9.71 | ||||
Asset Turnover | |||||||||
Asset Turnover | 0.43 | 0.28 | 0.26 | 0.3 | 0.38 | ||||
Fixed Assets Turnover | 12.66 | 7.42 | 4.74 | 2.97 | 2.9 | ||||
Receivables Turnover (Average Receivables) | 6.06 | 6.12 | 6.72 | 6.17 | 6.66 | ||||
Inventory Turnover (Average Inventory) | 1.32 | 1.25 | 1.01 | 0.9 | 0.98 | ||||
Short Term Liquidity | |||||||||
Current Ratio | 3.41 | 5.34 | 3.74 | 4.16 | 3.18 | ||||
Quick Ratio | 2.48 | 4.6 | 2.83 | 2.82 | 1.79 | ||||
Operating Cash Flow to Current Liabilities | 0.69 | 0.4 | 0.16 | -0.27 | 0.26 | ||||
Days Sales Outstanding (Average Receivables) | 60.44 | 59.64 | 54.34 | 59.16 | 54.98 | ||||
Days Outstanding Inventory (Average Inventory) | 276.72 | 292.51 | 361.01 | 405.88 | 374.26 | ||||
Average Days Payable Outstanding | 84.23 | 85.77 | 72.77 | 96.06 | 65.79 | ||||
Cash Conversion Cycle (Average Days) | 252.93 | 266.38 | 342.58 | 368.98 | 363.45 | ||||
Long Term Solvency | |||||||||
Total Debt/Equity | - | 0.12 | 3.38 | 0.15 | 3.89 | ||||
Total Debt / Total Capital | - | 0.12 | 3.27 | 0.15 | 3.75 | ||||
LT Debt/Equity | - | 0.03 | 3.3 | 0.09 | 3.71 | ||||
Long-Term Debt / Total Capital | - | 0.03 | 3.2 | 0.09 | 3.57 | ||||
Total Liabilities / Total Assets | 24.68 | 16.69 | 22.72 | 17.2 | 24.72 | ||||
EBIT / Interest Expense | 493.5 | 665 | 187.14 | 84.51 | 86.37 | ||||
EBITDA / Interest Expense | 607.49 | 735.57 | 197.16 | 89.48 | 94.44 | ||||
(EBITDA - Capex) / Interest Expense | -358.05 | -204.03 | -155.16 | 3.35 | -18.33 | ||||
Total Debt / EBITDA | - | 0.03 | 0.57 | 0.02 | 0.53 | ||||
Net Debt / EBITDA | -16.64 | -23.32 | -10.53 | -6.94 | -5.37 | ||||
Total Debt / (EBITDA - Capex) | - | -0.13 | -0.72 | 0.55 | -2.72 | ||||
Net Debt / (EBITDA - Capex) | 28.24 | 84.07 | 13.38 | -185.67 | 27.69 | ||||
Growth Over Prior Year | |||||||||
Total Revenues, 1 Yr. Growth % | 16.76 | 36.72 | 52.5 | 32.15 | 44.73 | ||||
Gross Profit, 1 Yr. Growth % | 34.87 | 58.18 | 59.51 | 32.36 | 31.51 | ||||
EBITDA, 1 Yr. Growth % | -16.56 | 127.19 | 73.21 | 27.81 | 5.06 | ||||
EBITA, 1 Yr. Growth % | -25.33 | 146.38 | 77.47 | 26.29 | 1.49 | ||||
EBIT, 1 Yr. Growth % | -20.6 | 236.01 | 103.08 | 38.36 | 9.63 | ||||
Earnings From Cont. Operations, 1 Yr. Growth % | 161.06 | 105.41 | 15.49 | 52.75 | -9.51 | ||||
Net Income, 1 Yr. Growth % | 161.02 | 105.49 | 15.66 | 52.67 | -9.53 | ||||
Normalized Net Income, 1 Yr. Growth % | -1.51 | 296.93 | 70.99 | 89.14 | -27.94 | ||||
Diluted EPS Before Extra, 1 Yr. Growth % | 148.65 | 91.3 | 7.95 | 51.58 | -9.72 | ||||
Accounts Receivable, 1 Yr. Growth % | 4.89 | 64.27 | 23.54 | 60.3 | 17.82 | ||||
Inventory, 1 Yr. Growth % | -2.22 | 65.65 | 93.04 | 25.23 | 65.21 | ||||
Net Property, Plant and Equip., 1 Yr. Growth % | 21.26 | 225.48 | 112.04 | 110.64 | 18.24 | ||||
Total Assets, 1 Yr. Growth % | 21.51 | 188.46 | 19.73 | 7.44 | 21.8 | ||||
Tangible Book Value, 1 Yr. Growth % | 18.07 | 227.64 | 11.42 | 15.08 | 11.11 | ||||
Common Equity, 1 Yr. Growth % | 16.47 | 219.06 | 11.08 | 15.13 | 10.72 | ||||
Cash From Operations, 1 Yr. Growth % | 535.02 | 20.08 | -39.24 | -258.2 | -249.28 | ||||
Capital Expenditures, 1 Yr. Growth % | 460.58 | 87.15 | 170.6 | -25.09 | 40.41 | ||||
Levered Free Cash Flow, 1 Yr. Growth % | -1.23K | 12.5 | -504.92 | 65.28 | -65 | ||||
Unlevered Free Cash Flow, 1 Yr. Growth % | -1.25K | 12.58 | -503.42 | 64.94 | -65.25 | ||||
Dividend Per Share, 1 Yr. Growth % | - | - | - | - | -40 | ||||
Compound Annual Growth Rate Over Two Years | |||||||||
Total Revenues, 2 Yr. CAGR % | 17.76 | 26.35 | 44.4 | 41.96 | 38.3 | ||||
Gross Profit, 2 Yr. CAGR % | 22.16 | 46.06 | 58.25 | 45.3 | 28.95 | ||||
EBITDA, 2 Yr. CAGR % | 23.86 | 57.25 | 110.14 | 55.46 | 20.45 | ||||
EBITA, 2 Yr. CAGR % | 23.12 | 58.99 | 122.33 | 56.71 | 17.91 | ||||
EBIT, 2 Yr. CAGR % | 24.65 | 63.34 | 161.22 | 67.62 | 23.15 | ||||
Earnings From Cont. Operations, 2 Yr. CAGR % | 132.8 | 131.57 | 54.02 | 32.82 | 17.57 | ||||
Net Income, 2 Yr. CAGR % | 132.74 | 131.6 | 54.16 | 32.88 | 17.52 | ||||
Normalized Net Income, 2 Yr. CAGR % | 49.87 | 97.72 | 160.52 | 79.84 | 16.74 | ||||
Diluted EPS Before Extra, 2 Yr. CAGR % | 114.48 | 118.1 | 43.71 | 27.92 | 16.98 | ||||
Accounts Receivable, 2 Yr. CAGR % | -13.58 | 31.26 | 42.46 | 40.73 | 37.43 | ||||
Inventory, 2 Yr. CAGR % | -7.65 | 27.27 | 78.82 | 55.48 | 43.84 | ||||
Net Property, Plant and Equip., 2 Yr. CAGR % | 9.8 | 98.67 | 162.71 | 111.34 | 57.81 | ||||
Total Assets, 2 Yr. CAGR % | 28.14 | 87.22 | 85.84 | 13.42 | 14.39 | ||||
Tangible Book Value, 2 Yr. CAGR % | 40.02 | 96.69 | 91.06 | 13.23 | 13.08 | ||||
Common Equity, 2 Yr. CAGR % | 43.68 | 92.78 | 88.26 | 13.08 | 12.9 | ||||
Cash From Operations, 2 Yr. CAGR % | 80.03 | 176.14 | -14.58 | -1.95 | 53.68 | ||||
Capital Expenditures, 2 Yr. CAGR % | 183.65 | 268.82 | 125.04 | 42.37 | 2.56 | ||||
Levered Free Cash Flow, 2 Yr. CAGR % | -9.07 | 216.28 | 113.58 | 158.7 | -15.13 | ||||
Unlevered Free Cash Flow, 2 Yr. CAGR % | -8.1 | 219.11 | 113.26 | 157.95 | -15.49 | ||||
Compound Annual Growth Rate Over Three Years | |||||||||
Total Revenues, 3 Yr. CAGR % | 32.74 | 23.77 | 34.52 | 40.19 | 42.88 | ||||
Gross Profit, 3 Yr. CAGR % | 31.84 | 33.15 | 50.04 | 49.1 | 38.43 | ||||
EBITDA, 3 Yr. CAGR % | 28.03 | 65.66 | 68.76 | 83.33 | 40 | ||||
EBITA, 3 Yr. CAGR % | 28.13 | 72.49 | 71.81 | 89.83 | 39.3 | ||||
EBIT, 3 Yr. CAGR % | 28.25 | 73.48 | 75.64 | 111.35 | 45.5 | ||||
Earnings From Cont. Operations, 3 Yr. CAGR % | 154.35 | 123.29 | 83.64 | 53.6 | 16.87 | ||||
Net Income, 3 Yr. CAGR % | 154.33 | 123.27 | 83.75 | 53.66 | 16.9 | ||||
Normalized Net Income, 3 Yr. CAGR % | 54.28 | 107.36 | 88.38 | 134.15 | 32.58 | ||||
Diluted EPS Before Extra, 3 Yr. CAGR % | 281.96 | 106.46 | 72.52 | 46.29 | 13.89 | ||||
Accounts Receivable, 3 Yr. CAGR % | -9.03 | 7.06 | 28.64 | 48.17 | 32.63 | ||||
Inventory, 3 Yr. CAGR % | 5.99 | 12.2 | 46.23 | 58.8 | 58.66 | ||||
Net Property, Plant and Equip., 3 Yr. CAGR % | 2.2 | 57.72 | 103.03 | 144.06 | 74.14 | ||||
Total Assets, 3 Yr. CAGR % | 36.6 | 67.94 | 61.3 | 54.82 | 16.15 | ||||
Tangible Book Value, 3 Yr. CAGR % | 150.67 | 85.89 | 62.74 | 61.36 | 12.52 | ||||
Common Equity, 3 Yr. CAGR % | 154.13 | 87.45 | 60.41 | 59.79 | 12.29 | ||||
Cash From Operations, 3 Yr. CAGR % | 77.99 | 57.3 | 66.71 | 4.9 | 12.8 | ||||
Capital Expenditures, 3 Yr. CAGR % | 139.51 | 169.27 | 232.65 | 55.96 | 41.72 | ||||
Levered Free Cash Flow, 3 Yr. CAGR % | -26.31 | -10 | 243.58 | 96.08 | 42.88 | ||||
Unlevered Free Cash Flow, 3 Yr. CAGR % | -25.84 | -9.33 | 245.21 | 95.75 | 42.3 | ||||
Compound Annual Growth Rate Over Five Years | |||||||||
Total Revenues, 5 Yr. CAGR % | - | 38.52 | 37.29 | 30.75 | 36.02 | ||||
Gross Profit, 5 Yr. CAGR % | - | 39.35 | 41.83 | 37.68 | 41.22 | ||||
EBITDA, 5 Yr. CAGR % | - | 17.55 | 64.61 | 65.27 | 50.08 | ||||
EBITA, 5 Yr. CAGR % | - | 12.61 | 70.21 | 70.12 | 50.52 | ||||
EBIT, 5 Yr. CAGR % | - | 12.4 | 70.47 | 71.11 | 52.39 | ||||
Earnings From Cont. Operations, 5 Yr. CAGR % | - | 33.47 | 108.11 | 81.4 | 53.64 | ||||
Net Income, 5 Yr. CAGR % | - | 33.47 | 108.18 | 81.42 | 53.67 | ||||
Normalized Net Income, 5 Yr. CAGR % | - | 21.7 | 90.25 | 95.88 | 55.56 | ||||
Diluted EPS Before Extra, 5 Yr. CAGR % | - | 56.05 | 158.35 | 70.48 | 47.69 | ||||
Accounts Receivable, 5 Yr. CAGR % | - | 24.37 | 8.84 | 19.43 | 32.08 | ||||
Inventory, 5 Yr. CAGR % | - | 39.74 | 30.65 | 27.84 | 45.27 | ||||
Net Property, Plant and Equip., 5 Yr. CAGR % | - | 26.3 | 49.09 | 77.31 | 83.57 | ||||
Total Assets, 5 Yr. CAGR % | - | 73.04 | 54.5 | 43.54 | 40.59 | ||||
Tangible Book Value, 5 Yr. CAGR % | - | 72.36 | 124.87 | 52.46 | 40.69 | ||||
Common Equity, 5 Yr. CAGR % | - | 74.13 | 125.39 | 53.14 | 39.39 | ||||
Cash From Operations, 5 Yr. CAGR % | - | 58.5 | 32.7 | 30.2 | 61.37 | ||||
Capital Expenditures, 5 Yr. CAGR % | - | 59.16 | 146.07 | 108.68 | 107.77 | ||||
Levered Free Cash Flow, 5 Yr. CAGR % | - | - | 7.43 | 37.34 | 96.39 | ||||
Unlevered Free Cash Flow, 5 Yr. CAGR % | - | - | 7.77 | 37.79 | 96.62 |
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition















